Literature DB >> 22370666

Evaluation of treatment modalities and prognostic factors in children with congenital nasolacrimal duct obstruction.

Yasser H Al-Faky1, Nora Al-Sobaie, Ahmad Mousa, Hessa Al-Odan, Reem Al-Huthail, Essam Osman, Abdul Rahman Al-Mosallam.   

Abstract

PURPOSE: To evaluate the success rates of probing and silicone intubation and risk factors for failure of these procedures.
METHODS: This retrospective cohort study included patients who were diagnosed with congenital nasolacrimal duct obstruction (NLDO) and underwent probing or intubation as the primary procedure. Demographic data, clinical features, intraoperative, and postoperative data were evaluated. The patients were divided into four subgroups based on age: 12-24 months, 25-36 months, 37-48 months, and >48 months. The procedure was considered successful when all preoperative signs disappeared with normal dye disappearance test and a positive Jones primary dye test. Statistical analysis was performed to determine the risk factors for failure, and P < 0.05 was statistically significant.
RESULTS: The cohort comprised 350 subjects (162 males [46%]) who underwent a total of 454 nasolacrimal duct surgeries. The mean chronological age at time of surgery was 32.6 ± 22.1 months (range, 12-132 months). The overall success rate was 84.8%. Probing was performed 188 times, with a success rate of 80.3%; intubation was performed 266 times, with a success rate of 88%.
CONCLUSIONS: Intubation was more successful than probing in patients with bilateral congenital nasolacrimal duct obstruction, Down syndrome, history of acute dacryocystitis, lack of preoperative massage, or intraoperative observation of either a "tight" obstruction or obstruction at sites other than at the level of Hasner's valve. Primary nasolacrimal duct intubation should be considered in these higher risk patients. Copyright Â
© 2012 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22370666     DOI: 10.1016/j.jaapos.2011.07.020

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  13 in total

1.  A comparison between monocanalicular and pushed monocanalicular silicone intubation in the treatment of congenital nasolacrimal duct obstruction.

Authors:  Dima Andalib; Hossein Mansoori
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

2.  Effects of medication methods after simple and effective probing of lacrimal passage.

Authors:  Bin Lu; Hua-Ying Xie; Cai-Ping Shi; Chun-Si Xu; Mei-Hong Gu
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  Nasolacrimal duct intubation in the treatment of congenital nasolacrimal duct obstruction in older children.

Authors:  S Okumuş; V Öner; C Durucu; E Coşkun; Ü Aksoy; E Durucu; L Şahin; I Erbağcı
Journal:  Eye (Lond)       Date:  2015-10-09       Impact factor: 3.775

4.  Symptom based diagnosis of infant under one year in outpatient clinic.

Authors:  Sangyoun Han; Ungsoo Samuel Kim
Journal:  Korean J Ophthalmol       Date:  2014-05-19

5.  Outcome of monocanalicular intubation for complex congenital nasolacrimal duct obstruction: the role of age.

Authors:  Bahram Eshraghi; Hadi Ghadimi; Safoora Karami; Mojgan Nikdel
Journal:  Rom J Ophthalmol       Date:  2022 Jan-Mar

6.  Factors affecting treatment outcome in congenital nasolacrimal duct obstruction: A retrospective analysis from South India.

Authors:  Sahil Bhandari; Sabyasachi Sengupta; Dayakar Yadalla; Jayagayathri Rajagopalan; Girish Bharat Velis; Deepti Talele; Sameer Kushwaha
Journal:  Indian J Ophthalmol       Date:  2015-10       Impact factor: 1.848

7.  Primary probing for congenital nasolacrimal duct obstruction with manually curved Bowman probes.

Authors:  Didem Serin; Ibrahim Bulent Buttanri; Mehmet Sahin Sevim; Bahtinur Buttanri
Journal:  Clin Ophthalmol       Date:  2013-01-11

8.  Risk factors for developing congenital nasolacrimal duct obstruction.

Authors:  Faisal D Aldahash; Muhammad F Al-Mubarak; Saad H Alenizi; Yasser H Al-Faky
Journal:  Saudi J Ophthalmol       Date:  2013-10-10

9.  Nasal endoscopy in the management of congenital nasolacrimal duct obstruction.

Authors:  Yasser H Al-Faky
Journal:  Saudi J Ophthalmol       Date:  2013-11-13

10.  Combined Lacrimal Passage Probing and Tobramycin/Dexamethasone Ophthalmic Ointment Infiltration: A Minimally Invasive Surgical Procedure for Incomplete Nasolacrimal Duct Obstruction.

Authors:  Jianjiang Xu; Jiaxu Hong; Xinghuai Sun; Zuguo Liu; Alireza Mashaghi; Takenori Inomata; Yi Lu; Yimin Li; Dan Wu; Yujing Yang; Anji Wei; Yujin Zhao; Chun Lu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.